Innersight Labs
AcquiredEntrepreneur First '15London, GB · Founded 2015 · 2 known investors
Innersight Labs provides a cloud-based surgical planning platform that converts CT/MRT DICOM scans into 3D models, delivering results within two working days. It serves hospitals and surgeons, integrating directly with hospital PACS systems or via a web app.
Also known as Innersight · Innersight Labs Ltd · Innersight3D · ISL
Founders & leadership
Innersight Labs was founded in 2015 by Eoin Hyde.
Investors · 2
Also in the syndicate · 1
Company profile
researched Aug 2026Innersight Labs Ltd develops Innersight3D, software that converts standard-of-care CT and MRI scans into patient-specific interactive virtual 3D models used by surgeons for pre-operative and intraoperative planning. Clinicians upload a DICOM folder either through a two-click PACS integration or a web app; Innersight processes the scans into a 3D model within two working days, notifies users by email when the case is published, and the labelled model is then viewed and manipulated in the platform. Models can be viewed on mobile and desktop devices without specialist hardware. The company states it builds models for kidney, lung, liver, colorectal and prostate anatomy [0][3].
The company positions the product around affordability, absence of a learning curve or new hardware, fast turnaround, model detail, secure cloud-based data access, and direct hospital PACS integration [0]. It maintains a research page listing peer-reviewed publications and conference work covering renal reconstruction and surgical planning (International Brazilian Journal of Urology, May 2023; Journal of Clinical Urology, January 2022 and March 2021; International Journal of Computer Assisted Radiology and Surgery, April 2019; Journal of Urology, April 2018; BJU International editorial, December 2019), thoracic and lung cases (Frontiers in Surgery, March 2021; Asian Cardiovascular and Thoracic Annals, October 2020), a pelvic kidney case report (Urology, July 2020), an ERUS 2019 presentation, and a machine-learning segmentation method for abdominal CT published in the Medical Image Understanding and Analysis 2018 conference proceedings [1].
Innersight Labs was described in February 2024 as an AI-powered medical software company spun out of the School of Biomedical Engineering & Imaging Sciences at King's College London, employing eight people and also operating an office in India, at the point of its acquisition by KARL STORZ. Members of the team were to be based at King's newly opening London Institute for Healthcare Engineering (LIHE) [3].
Founding story
The company is described as a spin-out from the School of Biomedical Engineering & Imaging Sciences at King's College London. Co-founder Dr Eoin R. Hyde was a Royal Academy of Engineering Enterprise Fellow embedded within King's College London's department of Biomedical Engineering and Imaging Sciences, an award received in January 2018 that included £60,000 of grant funding, mentoring and entrepreneurial training and supported development of the business plan [2][3].
Business model
The company supplies a cloud-based software service to hospitals and surgical teams: clinicians submit scans and receive processed 3D models through the platform, with optional direct integration into hospital PACS systems. Sources describe the offering as affordable and requiring no new hardware, but do not state pricing or contracting terms [0].
Not stated in the available sources; the site markets the service to hospitals and clinicians and offers a free first demo 3D model, and the company has also received public grant funding (NIHR i4i Connect in 2017 and an NIHR i4i Real-world Deployment grant in 2021) [0][2].
Traction
Sources cite deployment at multiple NHS and international hospitals, with surgeon testimonials reporting routine use for robotic partial nephrectomy services and reductions in operating time of 17-20 minutes in one clinician's experience. Published studies include a 2019 retrospective study in which 3D models changed surgical approach in 19% of partial nephrectomy cases and increased surgeon confidence among 25 surveyed surgeons, and a 2023 survey of 100 expert urologists on 3D renal reconstruction's influence on planning. The company employed eight people at the time of acquisition [0][1][3].
Latest developments
On 12 February 2024 King's College London announced that Innersight Labs had been acquired by KARL STORZ; the company had eight employees and an office in India, and team members were to be based at King's London Institute for Healthcare Engineering. The company's website now identifies it as "Part of KARL STORZ" [0][1][2][3].
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
A specialist provider of virtual 3D surgical planning models with a published clinical evidence base and CE marking obtained in November 2019, deployed across NHS trusts and international hospitals; in February 2024 it was acquired by KARL STORZ, described by King's College London as a leading international MedTech company, whose executive vice president cited software and robotics ambitions as the rationale [0][2][3]. No competitor set is identified in the sources.
Stated differentiators include a two-working-day turnaround from scan receipt, two-click PACS integration alongside web upload, viewing on standard mobile and desktop devices without specialist hardware or a learning curve, affordability, and a body of peer-reviewed clinical evidence supporting changes in surgical planning and increased surgeon confidence [0][1][3].
Technology
Innersight3D extracts patient anatomy from standard CT and MRI DICOM data and reconstructs it into labelled, interactive 3D models delivered through a secure cloud platform viewable on mobile and desktop devices. King's College London describes the company as AI-powered medical software [3]. A company research publication describes an adaptive sampling scheme for training fully convolutional networks to perform semantic segmentation of abdominal tissue structures in CT, reported as achieving state-of-the-art results on the Visceral Anatomy3 Benchmark Challenge [1].
Go-to-market
Direct engagement with surgeons and NHS trusts, supported by clinical evidence generation, conference sponsorship and live surgical demonstrations. Examples include co-sponsoring the 4th International Conference in Sub-Lobar Resections & Evolving Techniques for Lung Cancer in Paris (January 2023), a live robotic partial nephrectomy using an Innersight model at the Future Surgery Show (November 2022), sponsorship of a renal cell carcinoma masterclass with India's Society of Genitourinary Oncologists (February 2022), clinical collaborators presenting posters at Brazilian urology congresses (2022), and media coverage including Sky News (November 2022) and BBC filming of a reconstruction. The website offers a free first demo 3D model as an entry point and lists selected NHS partners [0][2].
Hospitals, surgical departments and individual surgeons, principally in urology (partial nephrectomy, complex renal and horseshoe-kidney cases), thoracic surgery (segmentectomy, lung nodules) and colorectal surgery. Named users and testimonial sources include the Royal Free Hospital and Guy's Hospital in London, Frimley NHS Foundation Trust, James Cook University Hospital, East Kent Hospitals University NHS Foundation Trust, ICUA in Spain, Apollo Hospitals in India, Spitalul de Oncologie Monza in Romania and the Hospital of Brothers of Mercy Vienna [0][2].
Geography
Headquartered in the UK with an office in India at the time of acquisition; team members to be located at the London Institute for Healthcare Engineering on the St Thomas' Hospital campus. Users and collaborators are cited in the UK (NHS trusts including Royal Free, Guy's, Frimley, James Cook, East Kent), Spain, Romania, Austria, India and Brazil, and the product holds a CE mark permitting placement on the European and UK markets [0][2][3].
History
Recorded milestones begin with a March 2017 collaboration with the Translational Imaging Group at University College London on improved techniques, followed by an NIHR i4i Connect grant in November 2017 funding a retrospective study and a prospective feasibility study. In January 2018 co-founder Eoin Hyde received a Royal Academy of Engineering Enterprise Fellowship. In March 2019 the company became a founding industry partner of the London Medical Imaging & AI Centre for Value Based Healthcare, and in November 2019 it secured a CE mark allowing Innersight3D to be marketed in Europe and the UK for routine patient care. During July 2020 it provided free models and technical support to help UK and international surgical teams address the COVID-19 surgical backlog. In August 2021 it was awarded an NIHR i4i Real-world Deployment grant for a multi-centre randomised controlled trial of Innersight3D in kidney cancer surgery. In March 2022 Eoin Hyde was selected for the first Royal Academy of Engineering Enterprise Hub EXPLORE programme. In February 2024 the company was acquired by KARL STORZ [2][3].
Risks & controversies
No controversies, litigation or regulatory actions are reported in the available sources. Regulatory status noted is a CE mark obtained in November 2019 for placement on the European and UK markets [2].
Compiled by commissioned research from 4 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 13
launches, deals, and filingsKing's College London announced that its spin-out Innersight Labs Ltd, from the School of Biomedical Engineering & Imaging Sciences, had been acquired by international MedTech company KARL STORZ. At the time the company employed eight people and operated an office in India; team members were to be based at King's London Institute for Healthcare Engineering.
Innersight co-sponsored the 4th International Conference in Sub-Lobar Resections & Evolving Techniques for Lung Cancer, held in Paris, France.
Innersight3D appeared on Sky News, demonstrated by consultant urologist Mr Muddassar Hussain at Frimley NHS Foundation Trust.
A live robotic partial nephrectomy using an Innersight virtual 3D model was broadcast to the Future Surgery Show audience at the Excel Centre, performed by Mr Ben Challacombe and team at Guy's, with connectivity provided by Proximie.
Co-founder Dr Eoin Hyde won a place on the first Royal Academy of Engineering Enterprise Hub EXPLORE programme for deep tech companies, including preparation for the US market and an international mission to Massachusetts.
Innersight sponsored the 'Masterclass in Renal cell carcinoma' session of India's Society Of Genitourinary Oncologists, which included Dr N. Ragavan discussing use of Innersight3D in surgical planning.
Awarded an NIHR i4i Real-world Deployment grant for a multi-centre randomized controlled trial into patient outcomes for Innersight3D surgical planning assistance in kidney cancer surgeries.
Provided free 3D models and technical support to UK and international surgical staff to help tackle the backlog of delayed operations caused by Covid-19.
Secured CE mark allowing Innersight3D to be placed on the market within Europe and the UK to assist with surgical planning for routine patient care.
Became a founding industry partner of the London Medical Imaging & AI Centre for Value Based Healthcare, aimed at innovation and new technology opportunities for the NHS.
Co-founder Dr Eoin Hyde received a Royal Academy of Engineering Enterprise Fellowship including £60k grant funding, mentoring and entrepreneurial training, hosted within King's College London's department of Biomedical Engineering and Imaging Sciences.
Awarded an NIHR i4i Connect grant funding a retrospective study on the impact of virtual 3D models on surgical planning and patient education, and a prospective feasibility study on patient acceptability of Innersight3D.
Began collaborating with the Translational Imaging Group at University College London towards improved techniques.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 4
primary sources listed
- Innersight Labsinnersightlabs.com · web
4 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Innersight Labs do?
- UK medical software company turning CT/MRI scans into interactive 3D anatomical models for surgical planning; acquired by KARL STORZ.
- Who founded Innersight Labs?
- Innersight Labs was founded by Eoin Hyde in 2015.
- Who are Innersight Labs's investors?
- Innersight Labs's investors include Entrepreneur First.
- Where is Innersight Labs headquartered?
- Innersight Labs is headquartered in London, GB.